<DOC>
	<DOCNO>NCT01972828</DOCNO>
	<brief_summary>Haemodynamic optimization paramount importance septic shock , really consensual standardize first 6 hour treatment . Haemodynamic treatment include fluid loading management , vasoactive treatment oxygen transport optimization mainly base expert recommendation non-randomized trial . Recently , preload dependence index pulse pressure variation show accurate predict fluid responsiveness static index fill pressure . However , whether use preload dependence index change septic shock prognostic remain date unknown . The aim non-blinded randomize control trial ass whether haemodynamic optimization use preload dependence index pulmonary thermodilution 1. reduces septic shock duration assess administration duration vasoactive treatment ( primary end point ) , 2. reduces regional hypoperfusion assess arterial lactate , 3. reduces lung hydrostatic oedema link excessive fluid loading ( assessed PaO2/FIO2 ratio extravascular lung water ) . 4. reduces organ dysfunction ( assessed SOFA score ) , ICU stay 7 28 day mortality Control group manage algorithm use fill pressure drive haemodynamic treatment .</brief_summary>
	<brief_title>Early Haemodynamic Optimization Using Preload Dependence During Septic Shock = EHOSS-1</brief_title>
	<detailed_description />
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Hydroxyethyl Starch Derivatives</mesh_term>
	<criteria>age 18 year fulfilment two four criterion systemic inflammatory response syndrome systolic blood pressure high 90 mm Hg ( crystalloidfluid challenge 25 ml per kilogram body weight 30minute period ) document suspected infection delay first observation hypotension inclusion 12 hour pregnancy acute coronary syndrome acute cerebral vascular event ( &lt; 1 month ) , contraindication central venous catheterization superior vena cava territory contraindication femoral arterial catheterization active haemorrhage burn injury trauma requirement immediate surgery ( &lt; 6 hour ) acute pulmonary oedema cardiogenic origin donotresuscitate status , advance directive restrict implementation protocol . Informed consent obtain patient surrogate Patient already include another therapeutic trial patient previously include therapeutic trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Septic shock</keyword>
	<keyword>Randomized control trial</keyword>
	<keyword>Preload dependence</keyword>
	<keyword>Pulmonary thermodilution</keyword>
</DOC>